Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of H1N1 Vaccines in Children
NCT00976820Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Mar 2011
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of recombinant influenza ha vaccine (h5n1), GSK2340273A in influenza, sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
recombinant influenza ha vaccine (h5n1)GSK2340273A
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00976820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976820.